Rapid Micro Biosystems Inc
NASDAQ:RPID
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Rapid Micro Biosystems Inc
Income from Continuing Operations
Rapid Micro Biosystems Inc
Income from Continuing Operations Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Rapid Micro Biosystems Inc
NASDAQ:RPID
|
Income from Continuing Operations
-$47.1m
|
CAGR 3-Years
8%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Income from Continuing Operations
$6.8B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
1%
|
CAGR 10-Years
13%
|
|
|
Danaher Corp
NYSE:DHR
|
Income from Continuing Operations
$3.7B
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
8%
|
|
|
Waters Corp
NYSE:WAT
|
Income from Continuing Operations
$642.6m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
4%
|
CAGR 10-Years
3%
|
|
|
Agilent Technologies Inc
NYSE:A
|
Income from Continuing Operations
$1.3B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
10%
|
CAGR 10-Years
11%
|
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Income from Continuing Operations
$1.3B
|
CAGR 3-Years
7%
|
CAGR 5-Years
35%
|
CAGR 10-Years
13%
|
|
Rapid Micro Biosystems Inc
Glance View
Rapid Micro Biosystems, Inc. is an innovative life sciences technology company. The company is headquartered in Lowell, Massachusetts and currently employs 220 full-time employees. The company went IPO on 2021-07-15. The firm provides automation solutions to facilitate the manufacturing and release of healthcare products, such as biologics, vaccines, cell and gene therapies, and sterile injectables. Its flagship Growth Direct platform automates and modernizes the manual microbial quality control (MQC), testing workflows used in pharmaceutical manufacturing operations across the globe. The Growth Direct platform helps on the manufacturing floor, unlocking the power of in-line/at-the-line MQC automation to deliver results with data regulations, and decision making that its customers rely on to ensure the supply of healthcare products. The Company’s Growth Direct platform is the automated MQC solution. The firm offers two consumables plates to capture test samples for analysis on the Growth Direct, which includes an Environmental Monitoring (EM), consumable and a Water/Bioburden (W/BB) consumable.
See Also
What is Rapid Micro Biosystems Inc's Income from Continuing Operations?
Income from Continuing Operations
-47.1m
USD
Based on the financial report for Dec 31, 2025, Rapid Micro Biosystems Inc's Income from Continuing Operations amounts to -47.1m USD.
What is Rapid Micro Biosystems Inc's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 5Y
-5%
Over the last year, the Income from Continuing Operations growth was 0%. The average annual Income from Continuing Operations growth rates for Rapid Micro Biosystems Inc have been 8% over the past three years , -5% over the past five years .
